annual CFI:
-$36.00M+$112.42M(+75.75%)Summary
- As of today (August 22, 2025), ELVN annual cash flow from investing activities is -$36.00 million, with the most recent change of +$112.42 million (+75.75%) on December 31, 2024.
- During the last 3 years, ELVN annual CFI has fallen by -$35.81 million (-18746.60%).
- ELVN annual CFI is now -147.05% below its all-time high of $76.52 million, reached on December 31, 2022.
Performance
ELVN Cash from investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFI:
-$183.59M-$185.02M(-12965.38%)Summary
- As of today (August 22, 2025), ELVN quarterly cash flow from investing activities is -$183.59 million, with the most recent change of -$185.02 million (-12965.38%) on June 30, 2025.
- Over the past year, ELVN quarterly CFI has dropped by -$149.92 million (-445.34%).
- ELVN quarterly CFI is now -338.35% below its all-time high of $77.03 million, reached on December 31, 2022.
Performance
ELVN quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFI:
-$166.61M-$149.92M(-898.56%)Summary
- As of today (August 22, 2025), ELVN TTM cash flow from investing activities is -$166.61 million, with the most recent change of -$149.92 million (-898.56%) on June 30, 2025.
- Over the past year, ELVN TTM CFI has dropped by -$118.20 million (-244.14%).
- ELVN TTM CFI is now -317.28% below its all-time high of $76.68 million, reached on March 31, 2023.
Performance
ELVN TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
ELVN Cash from investing Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +75.8% | -445.3% | -244.1% |
3 y3 years | -10000.0% | -10000.0% | -599.5% |
5 y5 years | -49.6% | -466.5% | -502.5% |
ELVN Cash from investing Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -147.1% | +75.8% | -338.4% | at low | -317.3% | at low |
5 y | 5-year | -147.1% | +75.8% | -338.4% | at low | -317.3% | at low |
alltime | all time | -147.1% | +75.8% | -338.4% | at low | -317.3% | at low |
ELVN Cash from investing History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2025 | - | -$183.59M(<-9900.0%) | -$166.61M(+898.6%) |
Mar 2025 | - | $1.43M(+96.3%) | -$16.68M(-53.6%) |
Dec 2024 | -$36.00M(-75.7%) | $727.00K(-95.1%) | -$36.00M(-1934.7%) |
Sep 2024 | - | $14.83M(-144.0%) | $1.96M(-104.1%) |
Jun 2024 | - | -$33.66M(+88.2%) | -$48.41M(-70.9%) |
Mar 2024 | - | -$17.89M(-146.2%) | -$166.27M(+12.0%) |
Dec 2023 | -$148.41M(-294.0%) | $38.69M(-208.8%) | -$148.41M(+34.8%) |
Sep 2023 | - | -$35.55M(-76.5%) | -$110.07M(+47.7%) |
Jun 2023 | - | -$151.52M(>+9900.0%) | -$74.54M(-197.2%) |
Mar 2023 | - | -$31.00K(-100.0%) | $76.68M(+0.2%) |
Dec 2022 | $76.52M | $77.03M(<-9900.0%) | $76.52M(-610.0%) |
Sep 2022 | - | -$14.00K(-95.4%) | -$15.00M(-37.0%) |
Jun 2022 | - | -$303.00K(+56.2%) | -$23.82M(+18.3%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2022 | - | -$194.00K(-98.7%) | -$20.13M(+1133.4%) |
Dec 2021 | -$191.00K(-98.9%) | - | - |
Dec 2021 | - | -$14.49M(+64.1%) | -$1.63M(-104.8%) |
Sep 2021 | - | -$8.83M(-360.7%) | $34.07M(+4.4%) |
Jun 2021 | - | $3.39M(-81.5%) | $32.62M(-1127.4%) |
Mar 2021 | - | $18.30M(-13.7%) | -$3.17M(-81.0%) |
Dec 2020 | -$16.72M(-30.5%) | $21.21M(-306.3%) | -$16.72M(-55.9%) |
Sep 2020 | - | -$10.28M(-68.3%) | -$37.93M(+37.2%) |
Jun 2020 | - | -$32.41M(-781.3%) | -$27.65M(-681.3%) |
Mar 2020 | - | $4.76M | $4.76M |
Dec 2019 | -$24.06M(<-9900.0%) | - | - |
Dec 2018 | $0.00(0.0%) | - | - |
Dec 2017 | $0.00 | - | - |
FAQ
- What is Enliven Therapeutics, Inc. annual cash flow from investing activities?
- What is the all time high annual CFI for Enliven Therapeutics, Inc.?
- What is Enliven Therapeutics, Inc. annual CFI year-on-year change?
- What is Enliven Therapeutics, Inc. quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Enliven Therapeutics, Inc.?
- What is Enliven Therapeutics, Inc. quarterly CFI year-on-year change?
- What is Enliven Therapeutics, Inc. TTM cash flow from investing activities?
- What is the all time high TTM CFI for Enliven Therapeutics, Inc.?
- What is Enliven Therapeutics, Inc. TTM CFI year-on-year change?
What is Enliven Therapeutics, Inc. annual cash flow from investing activities?
The current annual CFI of ELVN is -$36.00M
What is the all time high annual CFI for Enliven Therapeutics, Inc.?
Enliven Therapeutics, Inc. all-time high annual cash flow from investing activities is $76.52M
What is Enliven Therapeutics, Inc. annual CFI year-on-year change?
Over the past year, ELVN annual cash flow from investing activities has changed by +$112.42M (+75.75%)
What is Enliven Therapeutics, Inc. quarterly cash flow from investing activities?
The current quarterly CFI of ELVN is -$183.59M
What is the all time high quarterly CFI for Enliven Therapeutics, Inc.?
Enliven Therapeutics, Inc. all-time high quarterly cash flow from investing activities is $77.03M
What is Enliven Therapeutics, Inc. quarterly CFI year-on-year change?
Over the past year, ELVN quarterly cash flow from investing activities has changed by -$149.92M (-445.34%)
What is Enliven Therapeutics, Inc. TTM cash flow from investing activities?
The current TTM CFI of ELVN is -$166.61M
What is the all time high TTM CFI for Enliven Therapeutics, Inc.?
Enliven Therapeutics, Inc. all-time high TTM cash flow from investing activities is $76.68M
What is Enliven Therapeutics, Inc. TTM CFI year-on-year change?
Over the past year, ELVN TTM cash flow from investing activities has changed by -$118.20M (-244.14%)